Select Publications
Journal articles
2012, 'Cortical dysfunction underlies disability in multiple sclerosis', Multiple Sclerosis, 18, pp. 425 - 432, http://dx.doi.org/10.1177/1352458511424308
,2012, 'Corticomotoneuronal Integrity and Adaption in Spinal Muscular Atrophy', Archives of Neurology, 69, pp. 467 - 473, http://dx.doi.org/10.1001/archneurol.2011.1697
,2012, 'Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?', Amyotrophic Lateral Sclerosis, 13, pp. 245 - 250
,2012, 'Emergence of a predictive clinical biomarker for diabetic neuropathy', Diabetes, 61, pp. 1346 - 1347
,2012, 'Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals', Patient Preference and Adherence, 6, pp. 691 - 701, http://dx.doi.org/10.2147/PPA.S36759
,2012, 'FOSMN Syndrom : novel insight into diease pathophysiology', Neurology, 79, pp. 73 - 79
,2012, 'Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum', PloS One, 7, pp. e43993 - e43993, http://dx.doi.org/10.1371/journal.pone.0043993
,2012, 'Human T-lymphotropic virus seroconversion associated with pooled human intravenous immunoglobulin therapy.', Internal Medicine Journal, 42, pp. 729 - 730, http://dx.doi.org/10.1111/j.1445-5994.2012.02803.x
,2012, 'Hyperexcitability and amyotrophic lateral sclerosis', Neurology, 78, pp. 1544 - 1545
,2012, 'Impact of Oxaliplatin-induced Neuropathy: A Patient Perspective', Supportive Care in Cancer, 20, pp. 2959 - 2967, http://dx.doi.org/10.1007/s00520-012-1428-5
,2012, 'Impaired energy-dependent processes underlie acute lead neuropathy', Muscle and Nerve, 46, pp. 961 - 964, http://dx.doi.org/10.1002/mus.23425
,2012, 'In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission', Brain, 135, pp. 3144 - 3152, http://dx.doi.org/10.1093/brain/aws241
,2012, 'Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?', Amyotrophic Lateral Sclerosis, 13, pp. 521 - 527, http://dx.doi.org/10.3109/17482968.2012.673169
,2012, 'Letter on future care; an individualised disease-specific future care plan for people with ALS', BMJ Supportive & Palliative Care, 2, pp. 190.4 - 191, http://dx.doi.org/10.1136/bmjspcare-2012-000250.77
,2012, 'Longitudinal Assessment of Oxaliplatin-induced Neuropathy', Neurology, 78, pp. 152 - 152
,2012, 'Movement disorders: what lies beneath?', Journal of Neurology Neurosurgery and Psychiatry, 83, pp. 949 - 949, http://dx.doi.org/10.1136/jnnp-2012-303758
,2012, 'Nerve excitability assessment in chemotherapy-induced neurotoxicity', Journal of Visualized Experiments, 62, pp. 1 - 5, http://dx.doi.org/10.3791/3439
,2012, 'Potential utility of biomarkers in the diagnosis and treatment of amyotrophic lateral sclerosis', Clinical Investigation, 2, pp. 107 - 117, http://dx.doi.org/10.4155/cli.11.172
,2012, 'Response to Karam et al', Amyotrophic Lateral Sclerosis, 13, pp. 159 - 160
,2012, 'Saccadic abnormalities in frontotemporal dementia', Neurology, 78, pp. 1816 - 1823, http://dx.doi.org/10.1212/WNL.0b013e318258f75c
,2012, 'The relationship between cortical and spinal hyperexcitability and clinical disease severity in stiff-man syndrome.', Parkinsonism and Related Disorders, 18, pp. 1045 - 1047
,2012, 'Treatment of refractory neurosarcoidosis with TNF-inhibitors: what lies ahead?', Internal Medicine Journal, 42, pp. 232 - 232, http://dx.doi.org/10.1111/j.1445-5994.2011.02576.x
,2012, 'What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives.', Patient Preference and Adherence, 2, pp. 829 - 838, http://www.dovepress.com/what-influences-patient-decision-making-in-amyotrophic-lateral-scleros-peer-reviewed-article-PPA
,2012, 'What is impact?', Journal of Neurology Neurosurgery and Psychiatry, 83, pp. 1 - 2, http://dx.doi.org/10.1136/jnnp-2011-301738
,2011, 'Appearance, phenomenology and diagnostic utility of the split hand in amyotrophic lateral sclerosis', NEURODEGENERATIVE DISEASE MANAGEMENT, 1, pp. 457 - 462, http://dx.doi.org/10.2217/NMT.11.60
,2011, 'Cortical excitability distinguishes ALS from mimic disorders', CLINICAL NEUROPHYSIOLOGY, 122, pp. 1860 - 1866, http://dx.doi.org/10.1016/j.clinph.2010.12.062
,2011, 'A Teenager With Neck Pain', CLINICAL PEDIATRICS, 50, pp. 79 - 80, http://dx.doi.org/10.1177/0009922810378740
,2011, 'Activity-dependent conduction failure: Molecular insights', Journal of the Peripheral Nervous System, http://dx.doi.org/10.1111/j.1529-8027.2011.00358.x
,2011, 'Adaptation of motor function after spinal cord injury: novel insights into spinal shock', Brain, 134, pp. 495 - 505, http://dx.doi.org/10.1093/brain/awq289
,2011, 'Adaption of motor function after spinal cord injury: Novel insights into spinal shock', Brain, 134, pp. 495 - 505, http://dx.doi.org/10.1093/brain/awq289
,2011, 'Amyotrophic lateral sclerosis', Lancet, 377, pp. 942 - 955, http://dx.doi.org/10.1016/S0140-6736(10)61156-7
,2011, 'Clarifying variability of corticomotoneuronal function in kennedy disease', Muscle and Nerve, 44, pp. 197 - 201, http://dx.doi.org/10.1002/mus.22017
,2011, 'Clinical diagnosis and management of amyotrophic lateral sclerosis', Nature Reviews Neurology, 7, pp. 639 - 649, http://dx.doi.org/10.1038/nrneurol.2011.153
,2011, 'Cortical excitability distinguishes ALS from mimic disorders', Clinical Neurophysiology, 122, pp. 1860 - 1866, http://dx.doi.org/10.1016/j.clinph.2010.12.062
,2011, 'Dissecting the Mechanisms Underlying Short-Interval Intracortical Inhibition Using Exercise', Cerebral Cortex, 21, pp. 1639 - 1644, http://dx.doi.org/10.1093/cercor/bhq235
,2011, 'Dose effects of Oxaliplatin on persistent and transient na+ conductances and the development of neurotoxicity', PLoS One, 6, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0018469
,2011, 'Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy', Brain, 134, pp. 3185 - 3197, http://dx.doi.org/10.1093/brain/awr229
,2011, 'Early Progressive and Sustained Dysfunction of Sensory Axons Underlies Paclitaxel-induced Neuropathy', Muscle and Nerve, 43, pp. 367 - 374, http://dx.doi.org/10.1002/mus.21874
,2011, 'Freud, Neurology and the Emergence of Dynamic Neural Networks', Journal of Neurology Neurosurgery and Psychiatry, 82, pp. 120 - 120, http://dx.doi.org/10.1136/jnnp.2010.224998
,2011, 'How common are behavioural changes in amyotrophic lateral sclerosis?', Amyotrophic Lateral Sclerosis, 12, pp. 45 - 51, http://dx.doi.org/10.3109/17482968.2010.520718
,2011, 'Isolated bulbar phenotype of amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 12, pp. 283 - 289, http://dx.doi.org/10.3109/17482968.2011.551940
,2011, 'Long-term neuropathy after Oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248
,2011, 'Maladaptation of cortical circuits underlies fatigue and weakness in ALS.', Amyotrophic Lateral Sclerosis, 12, pp. 414 - 420, http://dx.doi.org/10.3109/17482968.2011.597403
,2011, 'Motor neuron dysfunction in frontotemporal dementia', Brain: A Journal of Neurology, 134, pp. 2582 - 2594, http://dx.doi.org/10.1093/brain/awr195
,2011, 'Motor neurone disease Caring for the patient in general practice', Australian Family Physician, 40, pp. 962 - 966, http://search.informit.com.au/documentSummary;dn=686583020346040;res=IELHEA
,2011, 'Nerve compression, membrane excitability, and symptoms of carpal tunnel syndrome', Muscle and Nerve, 44, pp. 402 - 409, http://dx.doi.org/10.1002/mus.22078
,2011, 'Nerve conduction studies', Australian Family Physician, 40, pp. 693 - 697
,2011, 'Neurophysiological index as a biomarker for ALS progression: Validity of mixed effects models', Amyotrophic Lateral Sclerosis, 12, pp. 33 - 38, http://dx.doi.org/10.3109/17482968.2010.531742
,2011, 'Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes', PloS One, 6, pp. e27041 - e27041, http://dx.doi.org/10.1371/journal.pone.0027041
,2011, 'Purple pigments: the pathophysiology of acute porphyric neuropathy', Clinical Neurophysiology, 122, pp. 2336 - 2344, http://dx.doi.org/10.1016/j.clinph.2011.07.036
,